Huatanqushihuoxue formula (HQHF) attenuates inflammation-cancer transformation in MASH-associated hepatocellular carcinoma: a potential association with the NETs/CD4+ T cell/Tregs related molecular signature

Background Huatanqushihuoxue formula (HQHF) exerts antioxidant and anti-inflammatory effects and alleviates hepatic inflammatory injury and fibrosis. Neutrophil extracellular traps (NETs) in the inflammatory microenvironment of metabolic dysfunction-associated steatohepatitis (MASH) regulate mitochondrial respiration in CD4 + T cells, promote regulatory T cell (Treg) differentiation, and mediate inflammation–cancer transformation. However, whether HQHF improves the immune microenvironment during MASH–hepatocellular carcinoma (HCC) progression by regulating the NETs/CD4 + T/Tregs axis remains unclear. This study aimed to investigate the correlation. Methods MASH-HCC rat models were established using a choline-deficient L-amino acid-defined (CDAA) diet combined with diethylnitrosamine (DEN) for 16 weeks. After HQHF intervention, liver function, lipid metabolism, inflammation, and tumor markers were measured. Western blotting, RT-qPCR, H&E staining, Oil Red O staining, and ELISA were used to analyze the regulatory effect of HQHF on the NETs/CD4 + T/Tregs pathway. Results Model rats showed obvious liver damage, steatosis, atypical hyperplasia, and tumor nodules, accompanied by disordered lipid metabolism, elevated inflammatory factors and tumor markers, and upregulated expressions of NETs, Tregs, and mitochondrial oxidative phosphorylation–related markers. HQHF treatment alleviated liver injury, reduced tumor nodules, corrected lipid metabolism disorders, and downregulated the expressions of Cit-H3, FoxP3, and NDUFB8 in liver tissue. Conclusion HQHF is positively correlated with the improvement of hepatic steatosis, inflammation, and fibrosis in MASH-HCC rats. HQHF may serve as a valuable intervention candidate for ameliorating inflammation-cancer transformation in MASH-HCC. Our study in MASH-HCC rat models indicates a potential association between HQHF and the NETs/CD4 + T/Tregs axis. Cellular-level studies are required to establish direct causality, offering preliminary evidence for MASH-HCC therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Hereditas
Published
2026-11-19
DOI
https://doi.org/10.1186/s41065-026-00771-x
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Huatanqushihuoxue formula (HQHF) attenuates inflammation-cancer transformation in MASH-associated hepatocellular carcinoma: a potential association with the NETs/CD4+ T cell/Tregs related molecular signature

Shanzheng Li, Sutong Liu, Tong Liu, Wenxia Zhao et al.
Hereditas
Liver Disease Diagnosis and Treatment
article

Huatanqushihuoxue formula (HQHF) attenuates inflammation-cancer transformation in MASH-associated hepatocellular carcinoma: a potential association with the NETs/CD4+ T cell/Tregs related molecular signature

Shanzheng Li, Sutong Liu, Tong Liu, Wenxia Zhao, Lihui Zhang, Cheng Zhou, Qing Zhao
article en

Abstract

Background Huatanqushihuoxue formula (HQHF) exerts antioxidant and anti-inflammatory effects and alleviates hepatic inflammatory injury and fibrosis. Neutrophil extracellular traps (NETs) in the inflammatory microenvironment of metabolic dysfunction-associated steatohepatitis (MASH) regulate mitochondrial respiration in CD4 + T cells, promote regulatory T cell (Treg) differentiation, and mediate inflammation–cancer transformation. However, whether HQHF improves the immune microenvironment during MASH–hepatocellular carcinoma (HCC) progression by regulating the NETs/CD4 + T/Tregs axis remains unclear. This study aimed to investigate the correlation. Methods MASH-HCC rat models were established using a choline-deficient L-amino acid-defined (CDAA) diet combined with diethylnitrosamine (DEN) for 16 weeks. After HQHF intervention, liver function, lipid metabolism, inflammation, and tumor markers were measured. Western blotting, RT-qPCR, H&E staining, Oil Red O staining, and ELISA were used to analyze the regulatory effect of HQHF on the NETs/CD4 + T/Tregs pathway. Results Model rats showed obvious liver damage, steatosis, atypical hyperplasia, and tumor nodules, accompanied by disordered lipid metabolism, elevated inflammatory factors and tumor markers, and upregulated expressions of NETs, Tregs, and mitochondrial oxidative phosphorylation–related markers. HQHF treatment alleviated liver injury, reduced tumor nodules, corrected lipid metabolism disorders, and downregulated the expressions of Cit-H3, FoxP3, and NDUFB8 in liver tissue. Conclusion HQHF is positively correlated with the improvement of hepatic steatosis, inflammation, and fibrosis in MASH-HCC rats. HQHF may serve as a valuable intervention candidate for ameliorating inflammation-cancer transformation in MASH-HCC. Our study in MASH-HCC rat models indicates a potential association between HQHF and the NETs/CD4 + T/Tregs axis. Cellular-level studies are required to establish direct causality, offering preliminary evidence for MASH-HCC therapeutic strategies.

Hereditas
Henan University of Traditional Chinese Medicine (CN), Wenzhou Hospital of Traditional Chinese Medicine (CN), First Affiliated Hospital of Henan University of Traditional Chinese Medicine (CN)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon